Quest Diagnostics Inc (DGX)

DGX (NYSE:Health Services)
$64.41
pos +0.00
+0.00%
Today's Range: 64.13 - 64.85 | DGX Avg Daily Volume: 1,485,400
Last Update: 11/21/14 - 4:02 PM EST
Volume: 0
YTD Performance: 20.30%
Open: $0.00
Previous Close: $63.52
52 Week Range: $50.46 - $64.85
Oustanding Shares: 144,534,244
Market Cap: 9,180,815,179
6-Month Chart
TheStreet Ratings Grade for DGX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 2 2 2
Moderate Buy 0 0 0 0
Hold 12 13 13 13
Moderate Sell 0 0 0 0
Strong Sell 3 3 3 3
Mean Rec. 2.96 3.07 3.07 3.07
Latest Dividend: 0.33
Latest Dividend Yield: 2.08%
Dividend Ex-Date: 10/03/14
Price Earnings Ratio: 18.15
Price Earnings Comparisons:
DGX Sector Avg. S&P 500
18.15 18.10 25.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
2.61% 4.77% 17.92%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.20 -0.03 -0.01
Net Income 49.10 0.12 0.04
EPS 60.60 0.37 0.11
Earnings for DGX:
EBITDA 1.32B
Revenue 7.15B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.05 $1.00 $4.06 $4.42
Number of Analysts 13 6 14 15
High Estimate $1.16 $1.05 $4.07 $4.83
Low Estimate $1.02 $0.97 $4.05 $4.30
Prior Year $1.03 $0.84 $4.00 $4.06
Growth Rate (Year over Year) 1.64% 18.45% 1.55% 8.78%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Get Some Positive Lab Results Real Money Pro($)

Try this options play for the sometimes volatile Bio-Reference Laboratories.
Bullish
May 08, 2014 | 7:58 AM EDT
DGX was upgraded to Neutral from Underperform, Bank of America/Merrill Lynch said. $58 price target. Had positive meetings with managem...
Bullish
Apr 14, 2014 | 8:19 AM EDT
Shares of DGX now seen reaching $62, according to Credit Suisse. Estimates also upped, given better reimbursement trends and the Solsta...
Update
Feb 25, 2014 | 7:12 AM EST
RBC Capital Markets Healthcare Conference
Bearish
Jan 31, 2014 | 8:10 AM EST
DGX cut its numbers, UBS said. 1Q14 expected to be impacted by sequestration and weather. $56 price target and Neutral rating. 
Quest Diagnostics -- and others in this beaten-down sector -- are excellent trading vehicles.
Bearish
Dec 10, 2013 | 7:23 AM EST
DGX was downgraded to Underperform, Bank of America/Merrill Lynch said. $55 price target. Expect weak growth and pricing prospects to c...
Bullish
Aug 08, 2013 | 7:59 AM EDT
DGX was upgraded from Hold to Buy, Maxim Group said. $73 price target. New management team is cutting costs and working to restore grow...
Bullish
Jul 19, 2013 | 8:09 AM EDT
DGX estimates were raised on increased buybacks, said UBS. Price target increased to $61.
Update
Jul 12, 2013 | 7:16 AM EDT
DGX was initiated with a Neutral rating, Robert Baird said. $58 price target. Turnaround story may still take some time.   

Columnist Conversations

Well this is confusing...our models were calling for a run to 2072 before a bearish reversal would be possible...
Revenue Trend Apple is one of the most remarkable companies in the world, not just because it has the largest...
HOG has topped out. The stock's twelve day winning streak is ending today with and ugly reversal. HOG o...
Seems like there was a bid underneath at the crucial 2:45 p.m. hour.. day saver? still not sure..

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.